IndraLab

Statements

KCNH2-N588K inhibits Class III. 1 / 1

| 1

reach

"The N588K hERG mutation is well established to attenuate markedly the inhibitory actions of Class III but not Class Ia antiarrhythmic drugs (which depend less than do Class III I Kr -selective drugs on channel inactivation to bind) XREF_BIBR."

21777565

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

KCNH2-N588K inhibits Class III. 1 / 1

INDRA sources:

Databases

Reading